Navigation Links
Spherix to Present at the BIO-Windhover/Pharmaceutical Strategic Outlook 2011 Conference
Date:3/22/2011

development while exploring D-tagatose as a potential treatment for high triglycerides, a risk factor for atherosclerosis, myocardial infarction, and stroke. Spherix's Consulting subsidiary provides scientific and strategic support for suppliers, manufacturers, distributors and retailers of conventional foods, biotechnology-derived foods, medical foods, infant formulas, food ingredients, dietary supplements, food contact substances, pharmaceuticals, medical devices, consumer products and industrial chemicals and pesticides.  For more information, please visit www.spherix.com.

Forward-Looking Statements

This release contains forward-looking statements which are made pursuant to provisions of Section 21E of the Securities Exchange Act of 1934. Investors are cautioned that such statements in this release, including statements relating to planned clinical study design, regulatory and business strategies, plans and objectives of management and growth opportunities for existing or proposed products, constitute forward-looking statements which involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the forward-looking statements. The risks and uncertainties include, without limitation, risks that product candidates may fail in the clinic or may not be successfully marketed or manufactured, we may lack financial resources to complete development of D-tagatose, the FDA may interpret the results of studies differently than us, competing products may be more successful, demand for new pharmaceutical products may decrease, the biopharmaceutical industry may experience negative market trends, our continuing efforts to develop D-tagatose may be unsuccessful, our common stock could be delisted from the Nasdaq Capital Market, and other risks and challenges detailed in our filings with the U.S. Securities and Exchange Commission. Readers are cautioned not to place
'/>"/>

SOURCE Spherix Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Spherix Receives Nasdaq Letter Extending Minimum Bid Price Compliance Period
2. Spherix Transfers Stock Listing to Nasdaq Capital Market
3. Spherix Reports 3rd Quarter Earnings
4. Spherix Announces 2008 Financial Results
5. Spherix Recruiting New Independent Director to Regain NASDAQ Compliance
6. Spherix Incorporated Announces the Death of A. Paul Cox, Jr., Chairman of the Board
7. Spherix to Exhibit at the BIO 2009 International Convention
8. Spherix Regains Full NASDAQ Compliance
9. Spherix Announces Full-Scale Production of Pharmaceutical Tagatose
10. Spherix Announces Termination of Arla License Agreement
11. Spherix Reports Second Quarter 2009 Earnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... CIO Review ( http://www.cioreview.com ) has chosen MMIS ... and Life Science Technology Solution Providers 2015. The positioning ... for life sciences companies. , The annual list ... and members of CIO Review’s editorial board to recognize ... on our radar for some time now for stirring ...
(Date:4/17/2015)... -- US-Australian drug discovery company, Novogen, today announced that ... the Feinstein Institute for Medical Research (,Feinstein Institute,) ... collaborate with the objective of developing effective treatments ... together the drug discovery expertise of Novogen and ... Institute in neurosciences and oncology. At ...
(Date:4/17/2015)... April 17, 2015 BellBrook Labs ... marketing support for the powerful Orthogonal Pooled Screening ... Genomics Center at the Lankenau Institute for Medical ... is to measurably improve successful drug discovery outcomes ... offering rare, drug-like libraries available nowhere else, coupled ...
(Date:4/16/2015)... April 16, 2015 Cambridge ... solutions driven by Semantic Web technology, and ... information and services for the academic and scientific, ... its joint solution ‘Smart Data Lake for Clinical ... for the 2015 Bio-IT ‘Best of Show’ Award. ...
Breaking Biology Technology:MMIS Chosen by CIO Review as Top 20 Most Promising Pharma and Life Science Technology Solution Providers 2015 2Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 2Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 3Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 4Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 5Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 6BellBrook Labs and Lankenau Institute Partner to Accelerate Drug Discovery using Orthogonal Pooled Screening 2Cambridge Semantics and Informa Named Bio-IT Award Finalist for Smart Data Lake Solution for Clinical Trial and Competitive Intelligence 2Cambridge Semantics and Informa Named Bio-IT Award Finalist for Smart Data Lake Solution for Clinical Trial and Competitive Intelligence 3
... March 31 PharmAthene, Inc.,(Amex: PIP ) ... chemical threats, today reported financial results for the,year ... President and Chief Executive Officer commented, "In,2007 we ... development,objectives and achieved a number of important milestones ...
... AVIV, Israel, March 31 Elbit Imaging Ltd.,(Nasdaq: ... announced its results for the,fiscal year 2007., ... the Company,s financial statements have been,prepared in accordance ... In accordance with the provisions of Standard ...
... Next Generation Pyrosequencing(R) System; PyroMark(TM)Q24 Pyrosequencing ... Low Throughput Epigenetic Studies, UPPSALA, Sweden, ... Biotage AB today announced the launch of ... Systems. This new high-performance,platform includes a complete ...
Cached Biology Technology:PharmAthene Reports Year-End 2007 Financial Results 2PharmAthene Reports Year-End 2007 Financial Results 3PharmAthene Reports Year-End 2007 Financial Results 4PharmAthene Reports Year-End 2007 Financial Results 5PharmAthene Reports Year-End 2007 Financial Results 6PharmAthene Reports Year-End 2007 Financial Results 7PharmAthene Reports Year-End 2007 Financial Results 8PharmAthene Reports Year-End 2007 Financial Results 9Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 2Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 3Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 4Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 5Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 6Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 7Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 8Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 9Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 10Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 11Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 12Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 13Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 14Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 15Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 16Biotage Launches New 24 Well Pyrosequencing(R) System 2
(Date:3/30/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/lc9bnl/global_gesture ) has ... Market in Automotive Sector 2014-2018" report to their ... Recognition market in Automotive Sector to grow at a ... Gesture recognition is the ability of a device to ... Gesture recognition technology can be 2D-based or 3D-based. It ...
(Date:3/24/2015)... Mar. 24, 2015 Research and Markets ... "Global Iris Recognition Market 2015-2019" report to ... Iris Recognition market to grow at a CAGR of ... report covers the present scenario and the growth prospects ... 2015-2019. To calculate the market size, the report considers ...
(Date:3/24/2015)...   NexID Biometrics LLC, whose spoof-mitigation technology ... announced the beginning of shipments of version 2.0 of ... company, based in Potsdam, N.Y. , ... which began here today at the Walter E. Washington ... its SDK boosts the accuracy rate range to 96.5 ...
Breaking Biology News(10 mins):Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2
... amounts of paved roads and impervious construction have lower ... a study from The University of Texas at Austin ... The study suggests that management strategies that reduce ... within the landscape could improve nesting opportunities for wild ...
... scale of tens of millions of years there is such a ... An anatomical difference in the ability to seize the moment, according ... species in one broad group, or clade, of grasses evolved a ... Their findings appear this week in the Proceedings of ...
... Current thinking on how the Toxoplasma gondii parasite ... today in Nature Methods describing a new technique ... other parasites from the same family, including malaria, and suggest ... invasion pathway may be unsuccessful. Toxoplasma gondii ...
Cached Biology News:Bumblebees do best where there is less pavement and more floral diversity 2Bumblebees do best where there is less pavement and more floral diversity 3Why some grasses evolved a more efficient photosynthesis and others didn't 2Why some grasses evolved a more efficient photosynthesis and others didn't 3Study turns parasite invasion theory on its head 2
Whole blood is collected from healthy guinea pigs of either sex from US source which are free of visible diseases at time of blood collection. Hemolytic titer: CH50 = 435 units...
... wells. ELISA.Specific for total MMP-3: Recognizes proMMP-3, ... with MMP-1, -2, -9. Range: 3.75-120 ng/ml. ... culture supernatant, serum, plasma and tissue samples.~ ... Category: Drug Screening & Cellular Assays, ...
... delivery of buffer and fixative results ... version. In Vivo Manual Perfusion Fixation ... of buffer and fixative results in ... use and clean--Complete system with everything ...
... to 1 outflow Single-cell and patch delivery ... millisecond) solution change Very small dead volume ... construction 360, 250 and 100 micron delivery ... any micromanipulator Available in 4, 8, and ...
Biology Products: